Insmed Incorporated
INSM
$116.00
$12.1111.66%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 819.56M | 606.42M | 447.02M | 398.11M | 381.03M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 819.56M | 606.42M | 447.02M | 398.11M | 381.03M |
| Cost of Revenue | 149.08M | 122.94M | 104.87M | 96.67M | 89.56M |
| Gross Profit | 670.48M | 483.49M | 342.15M | 301.43M | 291.47M |
| SG&A Expenses | 800.88M | 701.17M | 631.20M | 563.75M | 515.56M |
| Depreciation & Amortization | 6.82M | 6.00M | 5.33M | 5.05M | 5.05M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.78B | 1.60B | 1.44B | 1.33B | 1.24B |
| Operating Income | -965.22M | -994.78M | -990.28M | -927.68M | -859.01M |
| Income Before Tax | -1.18B | -1.27B | -1.18B | -1.03B | -1.01B |
| Income Tax Expenses | 5.58M | 5.03M | 4.74M | 4.44M | 4.03M |
| Earnings from Continuing Operations | -1.18K | -1.28K | -1.18K | -1.03K | -1.01K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.18B | -1.28B | -1.18B | -1.03B | -1.01B |
| EBIT | -965.22M | -994.78M | -990.28M | -927.68M | -859.01M |
| EBITDA | -949.04M | -980.46M | -978.79M | -917.46M | -849.84M |
| EPS Basic | -5.74 | -6.40 | -6.18 | -5.70 | -5.95 |
| Normalized Basic EPS | -3.00 | -3.21 | -3.33 | -3.29 | -3.22 |
| EPS Diluted | -5.75 | -6.41 | -6.19 | -5.71 | -5.95 |
| Normalized Diluted EPS | -3.00 | -3.21 | -3.33 | -3.29 | -3.22 |
| Average Basic Shares Outstanding | 830.17M | 795.56M | 760.94M | 722.90M | 688.30M |
| Average Diluted Shares Outstanding | 830.17M | 795.56M | 760.94M | 722.90M | 688.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |